Becker's Hospital Review

November 2019 Becker's Hospital Review

Issue link: https://beckershealthcare.uberflip.com/i/1179082

Contents of this Issue

Navigation

Page 15 of 79

16 CFO / FINANCE Cost of employer-based family health coverage hits record high: $20,576 By Morgan Haefner T he cost of health insurance offered to work- ers through their employers is increasingly unaffordable, according to an annual re- port from the Kaiser Family Foundation. The report, which included more than 2,000 in- terviews with nonfederal public and private firms, found annual premiums for employer-based family health insurance grew to $20,576 this year, surpassing $20,000 for the first time. Year over year, the cost of employer-sponsored family coverage is up 5 percent. On average, workers are paying $6,015 toward the cost of their cov- erage. The average premium for family coverage has grown 22 percent over the past five years, ac- cording to KFF. Over the past decade, premiums have grown 54 percent. This growth has signifi- cantly outpaced growth in workers' wages or in- flation. n Q2 brings smaller hikes to wholesale, net drug prices By Maia Anderson I ncreases to both wholesale and net drug prices trended down- ward in this year's second quarter, according to STAT. The quarter saw a 3.1 percent increase in wholesale drug prices, compared to 4.6 percent at the same time last year. Pricing actions were all crowded around zero, a more extreme decline in wholesale prices than previous cycles, STAT reported. Net prices also fell by 5.8 percent, compared to 6.1 percent in last year's second quarter. These trends are reflective of an increase in pressure from politicians on the pharmaceutical industry and pharmacy benefit managers to change their drug pricing policies, according to STAT. The wholesale price slowdown is likely to continue through the 2020 election and possibly longer, if drug pricing remains a political priority. The drop in wholesale and net prices can also be partially attributed to the fact that drugmakers didn't put price hikes on 47 percent of products, an "unprecedented" number, according to STAT. The second quarter was also unusual because "literally" no medi- cines, companies or market segments caused increases in net pric- es, STAT reported. All significant moves in the market contributed to drops in net pricing. n Medicare Advantage premiums to fall 23% next year, CMS says By Morgan Haefner P remiums for Medicare Advantage plans are slated to drop 23 percent from 2018, CMS said Sept. 24. CMS said premiums will be at their lowest since 2007. The lower premiums come as plan choic- es for Medicare Advantage enrollees increase. There are about 1,200 more Medicare Advan- tage plans active in 2020 than in 2018. Open enrollment for Medicare Advantage be- gins Oct. 15. CMS projects 24 million Americans will sign up for a Medicare Advantage plan in 2020. n Humana CEO: Competition, innovation key to lowering drug prices By Maia Anderson H umana CEO Bruce Broussard told CNBC that increasing competition and innovation among drugmakers is the best way to cut drug costs. "I really want to encourage competition because I think competition creates innovation, and when you create innovation everyone wins," Mr. Broussard told CNBC in an interview the day after House Speaker Nancy Pelosi released her much-anticipated drug-pricing plan. Mr. Broussard, who told CNBC he's not opposed to government assistance to reduce costs, said lawmakers should include rules to facilitate competition and innovation in their proposals to combat rising drug prices. He also said he favors rules that would create an out-of-pocket maxi- mum for Medicare beneficiaries, which is included in Ms. Pelosi's plan. n

Articles in this issue

view archives of Becker's Hospital Review - November 2019 Becker's Hospital Review